139 related articles for article (PubMed ID: 5556384)
21. Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy.
Folkers K; Nakamura R; Littarru GP; Zellweger H; Brunkhorst JB; Williams CW; Langston JH
Proc Natl Acad Sci U S A; 1974 May; 71(5):2098-102. PubMed ID: 4525474
[TBL] [Abstract][Full Text] [Related]
22. Hexahydrocoenzyme Q 4 in pseudohypertrophic muscular dystrophy.
Danowski TS; Folkers K; Wissinger HA; Hohmann TC; Gerneth JA; Vester JW
J Pharm Sci; 1971 Apr; 60(4):640-2. PubMed ID: 5128384
[No Abstract] [Full Text] [Related]
23. [Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD)].
Diotallevi P; Balducci E; Canapa A; Danni M; Giamagli CA; Lucesoli S; Ravaglia P; Milani-Comparetti M
Boll Soc Ital Biol Sper; 1988 Jun; 64(6):531-8. PubMed ID: 3190906
[No Abstract] [Full Text] [Related]
24. Carrier detection in X-linked Duchenne type muscular dystrophy. A pluridimensional investigation.
Radu H; Migea S; Török Z; Bordeianu L; Radu A
J Neurol Sci; 1968; 6(2):289-300. PubMed ID: 4179111
[No Abstract] [Full Text] [Related]
25. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
Zellweger H; Hanson JW
Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
[No Abstract] [Full Text] [Related]
26. [Contribution on the study of pseudohypertrophic muscular dystrophies. II. Pseudohypertrophic muscular dystrophies in females].
Radu H; Stenzel K
Dtsch Z Nervenheilkd; 1969; 196(2):116-35. PubMed ID: 5800953
[No Abstract] [Full Text] [Related]
27. The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy.
Thomson WH
Clin Chim Acta; 1969 Nov; 26(2):207-21. PubMed ID: 5352692
[No Abstract] [Full Text] [Related]
28. Biochemical and histopathological studies of the carrier state in Duchenne's muscular dystrophy.
Ionasescu V; Vuia O; Luca N; Popa P
Confin Neurol; 1968; 30(5):289-300. PubMed ID: 4891427
[No Abstract] [Full Text] [Related]
29. [Serum enzyme activities in progressive muscular dystrophy].
Yano I; Furukawa Y; Masaki H; Tani J
Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
[No Abstract] [Full Text] [Related]
30. A serum isozyme study in muscular dystrophy. Particular reference to creatine kinase, aspartate aminotransferase, and lactic acid dehydrogenase isozymes.
Somer H; Donner M; Murros J; Konttinen A
Arch Neurol; 1973 Nov; 29(5):343-5. PubMed ID: 4743886
[No Abstract] [Full Text] [Related]
31. [Serum enzymatic activity in neuromuscular diseases].
Strumień M
Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
[TBL] [Abstract][Full Text] [Related]
32. Benign sex-linked muscular dystrophy. Clinical and pathological features.
Markand ON; North RR; D'Agostino AN; Daly DD
Neurology; 1969 Jul; 19(7):617-33. PubMed ID: 5815127
[No Abstract] [Full Text] [Related]
33. [Modern laboratory methods for diagnosis and prevention of progressive dystrophy].
Mariani E; Bianchini A
Riv Neurol; 1968; 38(5):465-8. PubMed ID: 5699645
[No Abstract] [Full Text] [Related]
34. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].
Büsing CM; Heyck H; Laudahn G
Klin Wochenschr; 1969 Oct; 47(20):1099-103. PubMed ID: 5381991
[No Abstract] [Full Text] [Related]
35. Tabulation of findings in the muscular dystrophies and in myotonia dystrophica.
Danowski TS; Wissinger HA; Hohmann TC; Gerneth JA; Folkers K; Vester JW; Fisher ER
Arch Phys Med Rehabil; 1971 May; 52(5):193-200. PubMed ID: 4931852
[No Abstract] [Full Text] [Related]
36. Membrane abnormalities in Duchenne muscular dystrophy.
Jones GE; Witkowski JA
J Neurol Sci; 1983 Feb; 58(2):159-74. PubMed ID: 6300338
[No Abstract] [Full Text] [Related]
37. Biochemical aspects of genetically determined progressive muscular dystrophies.
Luca N; Haţegan D
Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
[No Abstract] [Full Text] [Related]
38. [Clinico-biochemical and genetic studies of myopathy].
Davidenkova EF; Droznina TA; Markelov IM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
[No Abstract] [Full Text] [Related]
39. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
[TBL] [Abstract][Full Text] [Related]
40. Biochemistry of muscle membranes in Duchenne muscular dystrophy.
Rowland LP
Muscle Nerve; 1980; 3(1):3-20. PubMed ID: 6445503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
